血清白蛋白浓度对腹膜透析患者再入院的影响  

Influence of Serum Albumin Levels on Readmission of Peritoneal Dialysis Patients

作　　者：冯永民[1] 陈秋萍[2] 唐蓉[1] 莫湛宇[1] 

机构地区：[1]广东医学院附属医院肾内科,广东湛江524001 [2]广东医学院附属医院老年病科,广东湛江524001

出　　处：《临床医学工程》2012年第8期1324-1325,共2页Clinical Medicine & Engineering

摘　　要：目的探讨血清白蛋白(Alb)浓度对腹膜透析患者再入院的影响。方法选取在我院首次诊断为尿毒症并开始行腹膜透析的两次或两次以上入院的患者43例。另选取同期未入院的腹膜透析患者31例作为对照组。记录腹膜透析患者开始透析时的年龄、性别、尿毒症的病因及Alb的浓度。记录患者再入院时的间隔时间、入院原因,及再入院时的Alb浓度。结果再入院组患者再入院时血清Alb浓度明显低于对照组患者,差异有统计学意义(P<0.05)。Logistic回归分析显示Alb浓度毎增加1g/L,患者再入院的风险减低8.5%。结论低蛋白血症可促使腹膜透析患者再入院,应积极纠正腹膜透析患者的低蛋白血症。Objective To investigate the influence of serum albumin on readmission of peritoneal dialysis patients. Methods 43 patients diagnozed as uremia for the first time who were in hospital for more than two times during peritoneal dialysis （PD） and 31 peritoneal dialysis patients who were not in hospital were both enrolled. Their ages, gender, protopathy, and serum albumin levels for the first PD were collected. Interval, readmission reason and serum albumin levels when readmission were recorded. Results Serum albumin levels in readmission patients were significantly lower than those in no readmission patients （P〈0.05）. Logistic regression analysis showed the risk of patient readmission would reduce by 8.5% when albumin levels increased by every 1 g/L. Conclusions Hypoproteinia can contribute to readmission in PD patients, which should be actively corrected in PD patients.

关 键 词：白蛋白 腹膜透析 再入院 

分 类 号：R459.5[医药卫生—治疗学]